WuXi Biologics (Cayman) Inc. – OTC:WXXWY
WuXi Biologics (Cayman) stock price today
$7.8
+3.39
+77.27%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market open
Closed in about 3 hours
WuXi Biologics (Cayman) stock price monthly change
+53.85%
month
WuXi Biologics (Cayman) stock price quarterly change
+53.85%
quarter
WuXi Biologics (Cayman) stock price yearly change
-37.32%
year
WuXi Biologics (Cayman) key metrics
Market Cap | 34.80B |
Enterprise value | 23.14B |
P/E | 47.7 |
EV/Sales | 2.24 |
EV/EBITDA | 5.91 |
Price/Sales | 17.10 |
Price/Book | 5.10 |
PEG ratio | 0.53 |
EPS | 1.77 |
Revenue | 32.30B |
EBITDA | 9.99B |
Income | 7.82B |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 32.93% |
Oper. margin | 33.67% |
Gross margin | 46.93% |
EBIT margin | 33.67% |
EBITDA margin | 30.95% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeWuXi Biologics (Cayman) stock price history
WuXi Biologics (Cayman) stock forecast
WuXi Biologics (Cayman) financial statements
| Jun 2022 | 7.20B | 2.53B | 35.18% |
|---|---|---|---|
| Dec 2022 | 8.06B | 1.88B | 23.38% |
| Jun 2023 | 8.49B | 2.26B | 26.69% |
| Dec 2023 | 8.54B | 1.13B | 13.26% |
| 2025 | 20.67B | 9.46B | 45.79% |
|---|---|---|---|
| 2026 | 23.68B | 11.07B | 46.73% |
| 2027 | 22.76B | 12.01B | 52.76% |
| 2028 | 20.92B | 21.50B | 102.73% |
Analysts Price target
Financials & Ratios estimates
| Jun 2022 | 47473253000 | 11.99B | 25.26% |
|---|---|---|---|
| Dec 2022 | 49564385000 | 13.35B | 26.94% |
| Jun 2023 | 52141232000 | 13.09B | 25.12% |
| Dec 2023 | 56575726000 | 12.55B | 22.2% |
| Jun 2022 | 1.45B | -2.36B | -218.94M |
|---|---|---|---|
| Dec 2022 | 4.08B | -3.54B | -2.37B |
| Jun 2023 | 782.72M | 0 | 0 |
| Dec 2023 | 0 | 0 | 0 |
WuXi Biologics (Cayman) alternative data
| Aug 2023 | 12,373 |
|---|---|
| Sep 2023 | 12,397 |
| Oct 2023 | 12,397 |
| Nov 2023 | 12,397 |
| Dec 2023 | 12,397 |
| Jan 2024 | 12,397 |
| Feb 2024 | 12,397 |
| Mar 2024 | 12,397 |
| Apr 2024 | 12,397 |
| May 2024 | 12,397 |
| Jun 2024 | 12,740 |
| Jul 2024 | 12,740 |
WuXi Biologics (Cayman) other data
Medpace: Clear Winner If China Blockade Succeeds
Week In Review: Abbisko Sells China Rights For CSF-1R Inhibitor To Merck In $605M Deal
Ajinomoto: Food, Biotech, And Semis All-In-One
Week In Review: BeiGene Signs $1.3 Billion Deal For Preclinical CDK2 Inhibitor From Boston's Ensem
Week In Review: QYuns Plans Hong Kong IPO For Autoimmune/Allergic Disease Portfolio
Biopharma Bounce-Back: From Policy Pains To Profitable Plains
Best Macro Pairs Trade Of 2023: Short ARKK And Long Healthcare
Week In Review: WuXi Biologics Out-Licenses 4 TCE Antibodies To GSK In $1.5 Billion Pact
Evotec SE: Profitable, Innovative, And The Omics Opportunity
-
What's the price of WuXi Biologics (Cayman) stock today?
One share of WuXi Biologics (Cayman) stock can currently be purchased for approximately $7.8.
-
When is WuXi Biologics (Cayman)'s next earnings date?
Unfortunately, WuXi Biologics (Cayman)'s (WXXWY) next earnings date is currently unknown.
-
Does WuXi Biologics (Cayman) pay dividends?
No, WuXi Biologics (Cayman) does not pay dividends.
-
How much money does WuXi Biologics (Cayman) make?
WuXi Biologics (Cayman) has a market capitalization of 34.80B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 11.56% to 17.03B US dollars.
-
What is WuXi Biologics (Cayman)'s stock symbol?
WuXi Biologics (Cayman) Inc. is traded on the OTC under the ticker symbol "WXXWY".
-
What is WuXi Biologics (Cayman)'s primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of WuXi Biologics (Cayman)?
Shares of WuXi Biologics (Cayman) can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does WuXi Biologics (Cayman) have?
As Jul 2024, WuXi Biologics (Cayman) employs 12,740 workers, which is 3% more then previous quarter.
-
When WuXi Biologics (Cayman) went public?
WuXi Biologics (Cayman) Inc. is publicly traded company for more then 6 years since IPO on 30 Nov 2018.
-
What is WuXi Biologics (Cayman)'s official website?
The official website for WuXi Biologics (Cayman) is wuxibiologics.com.
WuXi Biologics (Cayman) company profile:
WuXi Biologics (Cayman) Inc.
wuxibiologics.comExchange:
OTC
Full time employees:
10,593
Industry:
Biotechnology
Sector:
Healthcare
WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People's Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine CDMO and related business; and material supplier activities. WuXi Biologics (Cayman) Inc. has strategic partnership with ImmuneOncia Therapeutics, Legochem Biosciences Inc, Worg Pharma, OncoC4, and Exelixis Inc. The company was incorporated in 2014 and is headquartered in Wuxi, China.
No. 108, Meiliang Road
Wuxi, 214092
Wuxi, 214092
:
ISIN: US98260N1081
:
